Product Program year 2025 Source: CMS Open Payments

Cardioblate

Device Ablation

PDI 00885074266022

Open in the dashboard

General payments

$75,820

536 payments

Research payments

$1,087,806

427 payments

Through program year 2025, $75,820 in general payments and $1,087,806 in research payments were reported against Cardioblate (Ablation).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Amount Payments
2025 General $2,610 51
2025 Research $154,467 72
2024 General $4,725 52
2024 Research $177,958 68
2023 General $18,340 142
2023 Research $257,846 98
2022 General $17,266 122
2022 Research $271,187 119
2021 General $32,880 169
2021 Research $226,348 70

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $75,820 536 payments
Top recipients General payments · program year 2025
  1. Joseph Degregorio Cardiovascular Disease · Glen Ridge, NJ $268 10% · 2 payments
  2. Pranav Loyalka Cardiovascular Disease · Houston, TX $187 7% · 2 payments
  3. Anton Cherney Thoracic Surgery (Cardiothoracic Vascular Surgery) · Syracuse, NY $186 7% · 4 payments
  4. Jai Kumar Khatri Hospitalist · Indianapolis, IN $157 6% · 1 payment
  5. Antonio Moretta Clinical Cardiac Electrophysiology · Sarasota, FL $152 6% · 1 payment

The top 5 of 29 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,258 48% · 16 practitioners
  2. Cardiovascular Disease Internal Medicine $667 26% · 5 practitioners
  3. Clinical Cardiac Electrophysiology Internal Medicine $296 11% · 3 practitioners
  4. Hospitalist $262 10% · 2 practitioners
  5. Physician Assistant $84 3% · 1 practitioner

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $782 30% · 10 recipients
  2. Massachusetts $400 15% · 4 recipients
  3. New Jersey $268 10% · 1 recipient
  4. Florida $232 9% · 2 recipients
  5. Texas $187 7% · 1 recipient

The top 5 of 14 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

536 general · 427 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record